Treatment options for refractory angina in patients who are not candidates for revascularization

Current Cardiology Reports

Volumn 8, Issue 4, 2006, Pages 272-276

  Conti, C Richard ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; GLYCERYL TRINITRATE; RANOLAZINE; SODIUM;

CHRONIC DISEASE; CLINICAL PROTOCOL; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DAILY LIFE ACTIVITY; DRUG MECHANISM; FOLLOW UP; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; LOW LEVEL LASER THERAPY; PATIENT SAFETY; RANDOMIZATION; REVIEW; SPINAL CORD STIMULATION; STABLE ANGINA PECTORIS; SURVIVAL; SYMPTOM; UNITED STATES;

ANGINA PECTORIS; COMBINED MODALITY THERAPY; COUNTERPULSATION; ELECTRIC STIMULATION THERAPY; ENZYME INHIBITORS; HUMANS; MYOCARDIAL REVASCULARIZATION; PIPERAZINES; SPINAL CORD;

EID: 33745914931     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-006-0058-2     Document Type: Review

References (17)

1. Conti CR: The ABCs of modern management of chronic stable angina. Clin Cardiol 2005, 28:109-110.
2. Allen KB, Dowling RD, Fudge TL, et al.: Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med 1999, 341:1029-1036.
3. Hillis LD, Lange RA: Transmyocardial laser revascularization. N Engl J Med 1999, 341:1075-1076.
4. Arora RR, Chou TM, Jain D, et al.: Multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol 1999, 33:1833-1840.
5. Michaels AD, Linnemeier G, Soran O, et al.: Two-year outcomes after enhanced external counterpulsation for stable angina pectoris (from the International EECP Patient Registry [IEPR]). Am J Cardiol 2004, 93:461-464.
6. Conti CR: EECP-enhanced external counterpulsation. J Am Coll Cardiol 1999, 33:1841-1842.
7. Eliasson T, Augustinsson LE, Mannheimer C.: Spinal cord stimulation in severe angina pectoris - presentation of current studies, indications and clinical experience. Pain 1996, 65:169-179.
8. Mannheimer C, Augustinsson LE, Carlsson CA, et al.: Epidural spinal electrical stimulation in severe angina pectoris. Br Heart J 1988, 59:56-61.
9. DeJongste M, Haaksma J, Hautvast R, et al.: Effects of spinal cord stimulation on myocardial ischemia during daily life in patients with severe coronary artery disease. Br Heart J 1994, 71:413-418.
10. Lasagna L, Mosteller F, Felsinger J, et al.: A study of the placebo response. Am J Med 1954, 16:770-779.
11. Mannheimer C, Eliasson T, Augustinsson LE, et al.: A. electrical stimulation versus coronary artery bypass surgery in severe angina pectoris. The ESBY study. Circulation 1998, 97:1157-1163.
12. ten Vaarwerk IAM, Gessurun GHA, DeJongste MJL, et al.: for the Working Group on Neurocardiology: Clinical outcome of patients treated with spinal cord stimulation for therapeutically refractory angina pectoris. Heart 1999, 82:82-88.
13. Undrovinas AI, Undrovinas NA, Belardinelli L, et al.: Henry Ford Heart and Vascular Institute, Detroit MI, CV Therapeutics, Palo Alto, CA: Ranolazine inhibits late sodium current in isolated left ventricular myocytes of dogs with heart failure. J Am Coll Cardiol 2004, Abstract 1068-128.
14. Chaitman BR, Skettino SL, Parker JO, et al.: MARISA Investigators: Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. J Am Coll Cardiol 2004, 43:1375-1382.
15. Chaitman BR, Pepine CJ, Parker JO, et al.: Combination Assessment of Ranolazine In Stable Angina (CARISA) Investigators; Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. JAMA 2004, 291:309-316.
16. Belardinelli L, Antzelevitch C, Fraser H: Inhibition of late (sustained/ persistent) sodium current: a potential drug target to reduce intracellular sodium-dependent calcium overload and its detrimental effects on cardiomyocyte function. Eur Heart J 2004, 6 (Suppl 1):13-17.
17. Antzelevitch C, Belardinelli L, Zygmunt AC, et al.: Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties. Circulation 2004, 110:904-910.